135 related articles for article (PubMed ID: 37067109)
21. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course.
Mraz-Gernhard S; Natkunam Y; Hoppe RT; LeBoit P; Kohler S; Kim YH
J Clin Oncol; 2001 Apr; 19(8):2179-88. PubMed ID: 11304770
[TBL] [Abstract][Full Text] [Related]
22. Extranodal natural killer/T-cell lymphoma, nasal type, in Senegal.
Diallo M; Diop A; Diatta BA; Ndiaye M; Ortonne N; Dieng MT
Int J Dermatol; 2018 Apr; 57(4):401-405. PubMed ID: 29380871
[TBL] [Abstract][Full Text] [Related]
23. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
[TBL] [Abstract][Full Text] [Related]
24. [Clinicopathological features and prognosis of cytotoxic T-cell lymphoma: analysis of 134 cases].
Hou WH; Zhou XG; Xie JL; Zheng YL; Zhang X; Wang X
Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):290-295. PubMed ID: 35359038
[No Abstract] [Full Text] [Related]
25. CD30-positive cutaneous extranodal natural killer/T-cell lymphoma: clinicopathological features and survival outcomes.
Lee WJ; Moon IJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
Int J Dermatol; 2019 Jun; 58(6):688-696. PubMed ID: 30597548
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
27. [Expression of PDGFRA and CMYC in extranodal NK/T-cell lymphoma and their prognostic implications].
Chen YP; Zhu WF; Lin JY; He TM; Ma HM; Lu JP; Ye XA; Xu CW; Chen G
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):825-830. PubMed ID: 28056296
[No Abstract] [Full Text] [Related]
28. [Clinicopathologic features of intestinal natural killer/T-cell lymphoma].
Zhou J; Yu B; He Y; Wu B; Zhang XH; Zhou XJ; Shi QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):243-7. PubMed ID: 23928531
[TBL] [Abstract][Full Text] [Related]
29. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
30. Primary breast CD20-positive extranodal NK/T cell lymphoma with stomach involvement: a case report and literature review.
Zhang Y; Wang K; Tan Q; Yang K; Wu D; Xu Y; Zhao X; Jiang Z
Diagn Pathol; 2021 Nov; 16(1):103. PubMed ID: 34749754
[TBL] [Abstract][Full Text] [Related]
31. Rearranged T-cell receptor gene and positive Epstein-Barr virus-encoded nuclear RNA in an extranodal NK/T-cell lymphoma with cutaneous manifestation only: case study.
Wang J; Geng SA; Su Z; Xu J; Xu S; Wang F; Mo X; Feng Z
Clin Exp Dermatol; 2007 Nov; 32(6):744-8. PubMed ID: 17953643
[TBL] [Abstract][Full Text] [Related]
32. Intravascular NK/T-cell lymphoma: a report of five cases with cutaneous manifestation from China.
Wang L; Chen S; Ma H; Shi D; Huang C; Lu C; Gao T; Wang G
J Cutan Pathol; 2015 Sep; 42(9):610-7. PubMed ID: 25931234
[TBL] [Abstract][Full Text] [Related]
33. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
[TBL] [Abstract][Full Text] [Related]
35. Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population.
Chou CC; Tsao CF; Liao CK; You HL; Wang MC; Huang WT
Exp Mol Pathol; 2021 Feb; 118():104577. PubMed ID: 33242451
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression.
Brown HA; Macon WR; Kurtin PJ; Gibson LE
J Cutan Pathol; 2001 Sep; 28(8):432-8. PubMed ID: 11493382
[TBL] [Abstract][Full Text] [Related]
37. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.
Massone C; Chott A; Metze D; Kerl K; Citarella L; Vale E; Kerl H; Cerroni L
Am J Surg Pathol; 2004 Jun; 28(6):719-35. PubMed ID: 15166664
[TBL] [Abstract][Full Text] [Related]
38. Nasal-type extranodal natural killer/T-cell lymphoma presenting with extensive leg ulcers.
Chia HY; Tey HL; Tan KB; Chong WS
Clin Exp Dermatol; 2009 Dec; 34(8):e693-5. PubMed ID: 20055838
[TBL] [Abstract][Full Text] [Related]
39. Extranodal natural killer/T-cell lymphoma, nasal-type.
Chorianopoulos D; Samitas K; Vittorakis S; Kiriazi V; Rondoyianni D; Tsaousis G; Skoutelis A
Skinmed; 2010; 8(1):56-8. PubMed ID: 20839428
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous NK/T-cell lymphoma of nasal type: an age-related lymphoproliferative disease?
Wu CC; Takahashi E; Asano N; Miyata-Takata T; Takata K; Furukawa K; Elsayed AA; Hu LM; Satou A; Kohno K; Kosugi H; Ohashi K; Kinoshita T; Nakamura S; Kato S
Hum Pathol; 2017 Oct; 68():61-68. PubMed ID: 28873353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]